NP Antigen

Osivax, GC Biopharma Partner on Next-Gen Flu Vaccine

Lyon, France and Yongin, Republic of Korea, Aug. 26, 2026 Osivax, a clinical-stage biopharmaceutical company developing broad-spectrum influenza vaccines,...

By cGxPwire Editor
August 28, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

NP Antigen

Osivax, GC Biopharma Partner on Next-Gen Flu Vaccine